OBGEMSA

This brand name is authorized in Austria, Estonia, France, Italy, Lithuania.

Active ingredients

The drug OBGEMSA contains one active pharmaceutical ingredient (API):

1	Vibegron UNII M5TSE03W5U - VIBEGRON
	Vibegron is a selective and potent human beta-3 adrenergic receptor agonist over β1-AR and β2-AR. Activation of the beta-3 adrenergic receptor located in the bladder detrusor muscle increases bladder capacity by relaxing the detrusor smooth muscle during bladder filling.
	Read more about Vibegron

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OBGEMSA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD15		G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3083677, 3083688, 3083699
FR	Base de données publique des médicaments	69771112
IT	Agenzia del Farmaco	051355016, 051355028, 051355030, 051355042, 051355055, 051355067
LT	Valstybinė vaistų kontrolės tarnyba	1100112, 1100113, 1100114, 1100115, 1100116, 1100117